Revenue segments as reported by the company.

Clearing and transaction fees

Market data and information services

Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Compensation and benefits  

Technology

Professional fees and outside services

Amortization of purchased intangibles

Depreciation and amortization

Licensing and other fee agreements

Other expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CME Group

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CME Group achieves record-breaking 2022 performance amidst market challenges

CME Group's 2022 performance was exceptional, marked by record volumes, revenue growth, and successful transitions. The company's focus on innovation, strategic positioning in energy and cryptocurrency markets, and pricing adjustments have driven positive outcomes. Challenges in margins and market uncertainties require careful navigation.

CME Group posts record Q1 earnings, eyes growth in SOFR

CME Group delivered a strong performance in Q1 2023, achieving record revenue and profitability driven by growth in interest rate and options trading.
The company's strategic focus on risk management, shareholder value creation, and market competitiveness positions it well for future growth and revenue generation.
While facing challenges in a competitive market environment, CME Group has opportunities to capitalize on the demand for SOFR products and options trading.
Optimism surrounding the company's future growth potential, coupled with effective expense management and revenue diversification, underpin its resilience and strategic outlook.

CME Group excels in Q2 with record revenue and strategic focus

CME Group's Q2 earnings call showcased strong financial performance, driven by growth across asset classes and a focus on customer-centric strategies. The company's emphasis on innovation, regulatory compliance, and market leadership positions it well for future growth.

CME Group reports strong Q3 earnings, eyes growth amid challenges

CME Group's Q3 2023 earnings call highlighted robust financial performance, operational efficiency, and strategic positioning. Despite facing regulatory challenges and cost management concerns, the company remains confident in its offerings and growth prospects. Opportunities for expansion through innovation and capitalizing on market trends were key discussion points.

CME Group achieves record 2023 results amidst global uncertainties

CME Group's record-breaking performance in 2023 underscores its market leadership and financial strength, with revenue growth, margin expansion, and strong product demand driving positive results.
While facing challenges from global uncertainties and market dynamics, the company's strategic focus on innovation, risk management, and efficiency positions it well to capitalize on opportunities in evolving markets.
By introducing new products, expanding partnerships, and navigating changing market conditions adeptly, CME Group demonstrates resilience and adaptability, paving the way for continued growth and success in the financial industry.
Overall, CME Group's strategic initiatives, financial performance, and market positioning reflect a company poised for sustained success, leveraging opportunities and strengths to overcome challenges and drive future growth.

CME Group achieves record earnings in Q1 2024, eyes growth

CME Group delivered a strong performance in Q1 2024, setting records in revenue and earnings.
The company faces challenges in managing expenses amid growth initiatives and competitive dynamics.
However, CME's strengths in market leadership, network infrastructure, and regulatory alignment position it well for future opportunities.
By capitalizing on data services and revenue growth avenues, CME can continue its upward trajectory in the market.

CME Group achieves record Q3 performance amidst regulatory challenges

CME Group's Q3 performance was exceptional, marked by record volumes and financial metrics. Despite challenges in regulatory compliance and competition, the company is well-positioned for growth through strategic opportunities in interest rate products and retail expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intercontinental Exchange

Nasdaq

Coronavirus relief bill remained unsettled.

Why Intercontinental Exchange, Nasdaq, and CME Group Stocks All Declined Monday

A Relative Strength Rating upgrade for CME shows improving technical performance. Will it continue?

CME Shows Improved Relative Strength; Still Shy Of Benchmark

CME Group (CME) is poised to grow, given its solid global presence and strong capital position.

Here's Why Investors Should Hold on to CME Group Stock Now

The big securities market operator believes the concept, floated by Treasury Secretary Steven Mnuchin,  "makes no sense."

CME Group Slams Possibility of Shortened Trading Hours

CME (CME) reported earnings 30 days ago. What's next for the stock?

Why Is CME (CME) Down 17.3% Since Last Earnings Report?

Cboe Global Markets

The financial sector continues to get crushed in the market downturn, and the exchanges were hit especially hard.

Here's Why Intercontinental Exchange, CME Group, and CBOE Global Markets Fell on Thursday

CME Group (CME) is set to close its Chicago trading floor as a precautionary measure to reduce the spread of the coronavirus.

CME Group to Close Trading Floor Amid Coronavirus Outbreak

CME Group Inc. (NASDAQ: CME) will close its Chicago trading floor at the end of the session on Friday for an indefinite time, it announced Wednesday.

CME To Shut Down Chicago Trading Floor Over Coronavirus Concerns

Chicago-based exchange CME Group Inc., CME, -5.96% said on Wednesday that it will close its trading floor at the end of the week, as fear of the spread of COVID-19 grips financial markets.

CME Group will close trading floor until further notice amid coronavirus outbreak

CME Group announced Wednesday night it will close its Chicago trading floor in a precautionary move due to the coronavirus outbreak.

CME Group to close Chicago trading floor as a precaution due to coronavirus

MarketAxess Holdings

Solid Near-Term Outlook for Securities and Exchanges Industry

CME Group's (CME) average daily volume for February increases on the back of better contribution by all its six product lines.

CME Group (CME) February Volumes Solid, Up Year Over Year

Predata, a predictive analytics platform, formally announced it will be providing eight signal suites for commodity and fixed income products to CME Group, Inc.

CME Group Nabs Predata's Commodity, Fixed Income Signal Suites

Trading The Exchanges

CME Group (CME) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

CME Group (CME) in Focus: Stock Moves 5.7% Higher

Both international financial exchange managers are doing well, but one has major risks ahead.

Better Buy: CME Group vs. Intercontinental Exchange

CME Group Inc. (CME) CEO Terrence Duffy on Q4 2019 Results - Earnings Call Transcript

CME Group's (CME) Q4 results disappoint with lower revenues and contracting Average Daily Volume.

CME Group's (CME) Earnings Lag Estimates in Q4, Drop Y/Y

CME (CME) delivered earnings and revenue surprises of -1.30% and -0.74%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

CME Group (CME) Lags Q4 Earnings and Revenue Estimates

CME Group's (CME) Q4 results are likely to reflect lower revenues from declining volumes.

CME Group (CME) to Report Q4 Earnings: What's in Store?

CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CME Group (CME) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

CME is near a buy zone with earnings due on or around Feb. 12.

Stocks To Watch Ahead Of Earnings: CME

CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Can CME (CME) Keep the Earnings Surprise Streak Alive?

Battle Volatility By Buying The Exchanges

Two of the leading derivatives exchanges are poised for continued growth, but one is a better buy.

News for CME Group Stock (CME)